Literature DB >> 22297148

Advances in the understanding of the aetiology of Dupuytren's disease.

Natasha E Picardo1, Wasim S Khan.   

Abstract

Dupuytren's disease is a fibroproliferative disease of the palmar fascia which has been described for centuries, yet the aetiology and pathophysiology remain poorly understood. Surgery and collagenase injections comprise the main therapeutic options but disease recurrence is common. We explore the evidence underlying the current disease theories and outline other potential therapeutic options.
Copyright © 2012 Royal College of Surgeons of Edinburgh (Scottish charity number SC005317) and Royal College of Surgeons in Ireland. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22297148     DOI： 10.1016/j.surge.2012.01.004

Source DB:  PubMed          Journal:  Surgeon        ISSN： 1479-666X            Impact factor:   2.392


  9 in total

1.  SNPs previously associated with Dupuytren's disease replicated in a North American cohort.

Authors:  Eric R Anderson; Zhan Ye; Michael D Caldwell; James K Burmester
Journal:  Clin Med Res       Date:  2014-02-26

2.  MRI in flexor tendon rupture after collagenase injection.

Authors:  Shruti Khurana; Vibhor Wadhwa; Avneesh Chhabra; Bardia Amirlak
Journal:  Skeletal Radiol       Date:  2016-11-25       Impact factor: 2.199

Review 3.  Dupuytren's Disease: An Outcomes-Focused Update.

Authors:  Yasser H Almadani; Joshua Vorstenbosch; Johnny Ionut Efanov; Liqin Xu
Journal:  Semin Plast Surg       Date:  2021-07-06       Impact factor: 2.195

4.  Psychometric properties of health-related quality of life instruments in patients undergoing palmar fasciectomy for dupuytren's disease: a prospective study.

Authors:  Achilleas Thoma; Manraj Nirmal Kaur; Teegan Aili Ignacy; Carolyn Levis; Stuart Martin; Eric Duku; Ted Haines
Journal:  Hand (N Y)       Date:  2014-06

5.  Identification of histological patterns in clinically affected and unaffected palm regions in dupuytren's disease.

Authors:  Camilo-Andrés Alfonso-Rodríguez; Ingrid Garzón; Juan Garrido-Gómez; Ana-Celeste-Ximenes Oliveira; Miguel-Ángel Martín-Piedra; Giuseppe Scionti; Víctor Carriel; Pedro Hernández-Cortés; Antonio Campos; Miguel Alaminos
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

6.  Epidemiological analysis of patients with Dupuytren's disease.

Authors:  Henrique Gonçalves Mansur; Edmo Rodrigues de Oliveira; Cesar Barbosa Gonçalves
Journal:  Rev Bras Ortop       Date:  2017-12-14

7.  Blue light irradiation and its beneficial effect on Dupuytren's fibroblasts.

Authors:  Julia Krassovka; Annika Borgschulze; Benita Sahlender; Tim Lögters; Joachim Windolf; Vera Grotheer
Journal:  PLoS One       Date:  2019-01-11       Impact factor: 3.240

8.  Efficacy and safety of collagenase clostridium histolyticum for Dupuytren disease nodules: a randomized controlled trial.

Authors:  Bronier Costas; Stephen Coleman; Greg Kaufman; Robert James; Brian Cohen; R Glenn Gaston
Journal:  BMC Musculoskelet Disord       Date:  2017-08-30       Impact factor: 2.362

9.  Healthcare Costs and Resource Use of Patients with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum or Fasciectomy: A Propensity Matching Analysis.

Authors:  Vladimir Zah; Jovana Pelivanovic; Simona Tatovic; Djurdja Vukicevic; Martina Imro; Jane Ruby; David Hurley
Journal:  Clinicoecon Outcomes Res       Date:  2020-11-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.